U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients ...
that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...
On July 2, the FDA also approved a look-alike competitor, Kisunla. Case closed, many scientists have argued, although drugs ...
The FDA's approval is the first confirmation that a drug targets the underlying causes of Alzheimer's disease. Chuck Mann, father, grandfather, and mechanical engineer, his son Matthew cherished the ...
The FDA has approved a new Alzheimer's drug that offers hope for a slower cognitive decline. It's only the second drug that's ...
Cooling economic data raised rate-cut hopes. Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in ...
Click here to get the story. Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic ...
All the Whitneys ask is that visitors make a donation to a good cause. (Submitted by Gail Whitney) Gail says they decided to ...
As Fort Worth grows, researchers across various medical institutions discuss the future of local clinical research and its ...
Buying legitimate Back it Up Terry goods from family-approved sources helps the family pay for the gas used in the van. "It's ...
People have figured out how to get the drugs anyway. The new weight loss medications are approved by the Food and Drug ...